Integra LifeSciences Receives FDA 510(k) Clearance for Titanium Bone Wedges

Integra LifeSciences announced it has received 510(k) clearance from the U.S. Food and Drug Administration for the Integra Titanium Bone Wedges.

Advertisement

The bone wedges are designed for internal fixation of bone fractures or osteotomies in the foot and ankle.

 

“We’re very pleased that we can now offer surgeons another option to complete our flatfoot correction portfolio,” said Robert Paltridge, president of extremity reconstruction at Integra LifeSciences.

More Articles on Devices:

Is Biomet Next to Form IPO?
Bioventus Names VP of Global Marketing
Aurora Spine Appoints New VP of Sales

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.